The elderly (aged 65 and over) This product has not been evaluated in 65 years and the safety and efficacy in patients over the crowd used, the main reason for the data on this product for use in this population is extremely limited in patients with mild renal impairment or Patients with kidney damage do not need to adjust the dose when taking this product, but should take it with caution.
Kwabaneminyaka yobudala engama-65 nangaphezulu, Lo mkhiqizo awukahlolwa iminyaka engu-65 nokuphepha kanye nokusebenza kahle kweziguli ngaphezulu kwesixuku esisetshenzisiwe, isizathu esiyinhloko sedatha kulo mkhiqizo ukuze sisetshenziswe kuleli nani labantu lilinganiselwe kakhulu ezigulini ezinokulimazeka okuncane kwezinso. noma iziguli ezinomonakalo wezinso azidingi ukulungisa umthamo lapho uthatha lo mkhiqizo, kepha kufanele uwuthathe ngokuqapha.